FendX Technologies, Inc.
0.20
CAD
-0.03
(-14.89%)
ISIN
CA3144602057
CUSIP
314460205
Return %
Stock
S&P 500
1Y
-68.75
14.20
3Y
-93.65
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Carolyn J. Myers
- Sector
- Process industries
- Industry
- Industrial specialties
- Address
- Vancouver Canada
- IPO Date
- Mar 20, 2023
- Website
- fendxtech.com
- Similar Companies
- Business
- FendX Technologies Inc. is a nanotechnology and biotechnology company focused on the research, development, and commercialization of surface protection solutions designed to reduce the transmission of infectious pathogens. Incorporated in 2020 and headquartered in Vancouver, British Columbia, Canada, the company operates within the healthcare, commercial, and consumer hygiene sectors. FendX Technologies utilizes proprietary nanotechnology licensed exclusively and worldwide from McMaster University to engineer anti-pathogen coatings and diagnostic surface monitoring tools. The company's core product and technology portfolio comprises REPELWRAP film, a protective surface film engineered with repelling properties for high-touch surfaces such as door handles, railings, and touchscreens to prevent pathogen adhesion; bifunctional liquid and spray nanotechnology coatings, formulated for application via spray, brush, or roller to simultaneously repel and neutralize bacteria and viruses; medical catheter coatings, developed specifically for Foley catheters to provide low-friction, antimicrobial surfaces that inhibit biofilm formation and reduce catheter-associated infections; and an artificial intelligence-enabled surface contamination detection platform, combining colorimetric optical sensors with a mobile application to deliver real-time visual detection of bacterial presence on environmental surfaces. FendX Technologies targets institutional healthcare providers, medical device manufacturers, commercial real estate operators, public transit authorities, and industrial facilities across North America. In recent corporate developments, FendX Technologies has advanced its manufacturing and development initiatives through key strategic collaborations, including engaging Dunmore International Inc. for the scale-up and pilot manufacturing of REPELWRAP film and partnering with Galenvs Sciences Inc. for pilot-scale manufacturing of its liquid surface coating formulations. Additionally, the company established a collaborative agreement with Aquaox LLC to evaluate eco-friendly antimicrobial agents, filed provisional patent applications covering its advanced antimicrobial coating technologies, advanced technical design for its AI-driven contamination detection application, and completed private placement equity financings to fund ongoing product development, laboratory testing, and general corporate operations.